Role of COL4A1 in Small-Vessel Disease and Hemorrhagic Stroke
Open accessThe DOI matches its Crossref record; 16 of the 18 references it cites were found in a registry or an index.
Abstract
Small-vessel diseases of the brain underlie 20 to 30 percent of ischemic strokes and a larger proportion of intracerebral hemorrhages. In this report, we show that a mutation in the mouse Col4a1 gene, encoding procollagen type IV alpha1, predisposes both newborn and adult mice to intracerebral hemorrhage. Surgical delivery of mutant mice alleviated birth-associated trauma and hemorrhage. We identified a COL4A1 mutation in a human family with small-vessel disease. We concluded that mutation of COL4A1 may cause a spectrum of cerebrovascular phenotypes and that persons with COL4A1 mutations may be predisposed to hemorrhage, especially after environmental stress.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations of the COL4A1 type IV collagen subunit gene have also been reported in association with congenital porencephaly, leukoencephalopathy, or intracerebral hemorrhage.178,179”
In the citing paper
“COL4A1 and COL4A2 are major proteins of the basement membranes, and their transcripts are found in vascular endothelial cells and in many other cell types (210).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [210]
In the citing paper
“Mutations in COL4A1 and COL4A2 genes encoding the basement membrane collagen proteins COL4A1andCOL4A2leadtocerebral small vessel disease in humans associated with lacunar ischemic strokes, intracerebral hemorrhages, and white matter hyperintensities (210).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [210]
Citations
Cites
Alport's Syndrome, Goodpasture's Syndrome, and Type IV Collagen
Hudson, B. G., Tryggvason, K., Sundaramoorthy, M., & Neilson, E. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022296 · Cited by 963
Patton, N., Aslam, T., MacGillivray, T., Pattie, A., Deary, I. J., & Dhillon, B. (2005) · Journal of Anatomy · doi:10.1111/j.1469-7580.2005.00395.x · Cited by 807
(2010) · Handbook of Disease Burdens and Quality of Life Measures · doi:10.1007/978-0-387-78665-0_5946 · Cited by 665
Mutations in Col4a1 Cause Perinatal Cerebral Hemorrhage and Porencephaly
Gould, D. B., Phalan, F. C., Breedveld, G. J., van Mil, S. E., Smith, R. S., Schimenti, J. C., Aguglia, U., van der Knaap, M. S., Heutink, P., & John, S. W. M. (2005) · Science · doi:10.1126/science.1109418 · Cited by 541
Self-citationBader, B. L., Smyth, N., Nedbal, S., Miosge, N., Baranowsky, A., Mokkapati, S., Murshed, M., & Nischt, R. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6846-6856.2005 · Cited by 244
Hereditary endotheliopathy with retinopathy, nephropathy, and stroke(HERNS)
Jen, J., Cohen, A. H., Yue, Q., Stout, J. T., Vinters, H. V., Nelson, S., & Baloh, R. W. (1997) · Neurology · doi:10.1212/wnl.49.5.1322 · Cited by 207
Willem, M., Miosge, N., Halfter, W., Smyth, N., Jannetti, I., Burghart, E., Timpl, R., & Mayer, U. (2002) · Development · doi:10.1242/dev.129.11.2711 · Cited by 199
Novel mutations in three families confirm a major role of COL4A1 in hereditary porencephaly
Breedveld, G., de Coo, I. F., Lequin, M. H., Arts, W. F. M., Heutink, P., Gould, D. B., John, S. W. M., Oostra, B., & Mancini, G. M. S. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.035584 · Cited by 180
Self-citationVan Agtmael, T., Schlötzer-Schrehardt, U., McKie, L., Brownstein, D. G., Lee, A. W., Cross, S. H., Sado, Y., Mullins, J. J., Pöschl, E., & Jackson, I. J. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi348 · Cited by 145
Mouse fundus photography and angiography: a catalogue of normal and mutant phenotypes.
Hawes, N. L., Smith, R. S., Chang, B., Davisson, M. T., Heckenlively, J. R., & John, S. W. M. (1999) · PubMed · Cited by 143
Self-citation
Research works printed but not linked: 1
- Hawes NL, 1999, Mol Vis, 5, 22
Cited by
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
Stroke risk factors, genetics, and prevention
Boehme, A. K., Esenwa, C., & Elkind, M. S. V. (2017) · Circulation Research · doi:10.1161/circresaha.116.308398 · Cited by 1,952
“Cerebrovascular manifestations include small vessel steno-occlusive disease, aneurysms, and dolichoectasia, with resulting ischemia, intracranial hemorrhage, leukoencephalopathy, and retinal arteriolar tortuosity.(205) An increased tendency for cerebral hemorrhage can occur with head trauma, participation in sports, a…”
BackgroundEstablishment and Dysfunction of the Blood-Brain Barrier
Zhao, Z., Nelson, A. R., Betsholtz, C., & Zlokovic, B. V. (2015) · Cell · doi:10.1016/j.cell.2015.10.067 · Cited by 1,670
Malik, R., Chauhan, G., Traylor, M., Sargurupremraj, M., Okada, Y., Mishra, A., Rutten-Jacobs, L., Giese, A.-K., van der Laan, S. W., Gretarsdottir, S., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0058-3 · Cited by 1,599
Basement Membranes: Cell Scaffoldings and Signaling Platforms
Yurchenco, P. D. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004911 · Cited by 959
“…because of faulty chain assembly (hypomorph) have been associated with development of porencephaly and hemorrhagic stroke, suggesting a critical role of type IV collagen in the stabilization of themicrovasculature (Gould et al. 2005; Breedveld et al. 2006; Gould et al. 2006; Gould et al. 2007).”
Vitamin C function in the brain: Vital role of the ascorbate transporter SVCT2
Harrison, F. E., & May, J. M. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.12.018 · Cited by 661
“Milder variants of this defect in humans have been associated with small vessel disease and hemorrhagic stroke [172].”
BackgroundThe nature and biology of basement membranes
Pozzi, A., Yurchenco, P. D., & Iozzo, R. V. (2017) · Matrix Biology · doi:10.1016/j.matbio.2016.12.009 · Cited by 575
“Humans with COLA41 mutations were more recently found to develop small vessel disease and hemorrhagic stroke [23].”
BackgroundHemorrhagic Transformation after Ischemic Stroke in Animals and Humans
Jickling, G. C., Liu, D., Stamova, B., Ander, B. P., Zhan, X., Lu, A., & Sharp, F. R. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.203 · Cited by 547
The extracellular matrix as a multitasking player in disease
Theocharis, A. D., Manou, D., & Karamanos, N. K. (2019) · The FEBS Journal · doi:10.1111/febs.14818 · Cited by 511
The vascular basement membrane in the healthy and pathological brain
Thomsen, M. S., Routhe, L. J., & Moos, T. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17722436 · Cited by 490
“As previously mentioned, the Col4a1 mutation predisposes mice to haemorrhagic stroke, thus underlining the important role of collagen IV for vascular integrity.(46,72) Likewise, mutations or degradation of other basement membrane proteins are suggested to predispose to stroke.”
BackgroundAssociation of HTRA1 Mutations and Familial Ischemic Cerebral Small-Vessel Disease
Hara, K., Shiga, A., Fukutake, T., Nozaki, H., Miyashita, A., Yokoseki, A., Kawata, H., Koyama, A., Arima, K., Takahashi, T., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0801560 · Cited by 460
Kalaria, R. N. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1571-z · Cited by 441
“They include conditions with abnormalities in the skin and eye and multiple lacunar infarcts in the deep WM and pons [128], retinal arteriolar tortuosity and leukoencephalopathy [67, 166] and profound WM changes upon MRI [169].”
BackgroundExtracellular matrix and matrix receptors in blood–brain barrier formation and stroke
Baeten, K. M., & Akassoglou, K. (2011) · Developmental Neurobiology · doi:10.1002/dneu.20954 · Cited by 397
“Null mutations of either fibronectin or collagen IV are embryonic lethal due to mesoderm defects or impaired BM stability, respectively; and more modest mutations in the Col4a1 gene are associated with fragile vessels, which predispose to stress-induced hemorrhage and adult-onset stroke in humans and mice (George et a…”
BackgroundInfluentialBasement membrane and blood–brain barrier
Xu, L., Nirwane, A., & Yao, Y. (2019) · Stroke and Vascular Neurology · doi:10.1136/svn-2018-000198 · Cited by 352
COL4A1 Mutations and Hereditary Angiopathy, Nephropathy, Aneurysms, and Muscle Cramps
Plaisier, E., Gribouval, O., Alamowitch, S., Mougenot, B., Prost, C., Verpont, M. C., Marro, B., Desmettre, T., Cohen, S. Y., Roullet, E., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071906 · Cited by 367
Inoue, Y., Shue, F., Bu, G., & Kanekiyo, T. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00640-5 · Cited by 329
“Missense or null variants in COL4A1 and COL4A2 result in autosomal dominant cSVD [129].”
BackgroundDevelopmental and Pathogenic Mechanisms of Basement Membrane Assembly
Yurchenco, P., & Patton, B. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787846766 · Cited by 342
Lacunar stroke is associated with diffuse blood-brain barrier dysfunction
Wardlaw, J. M., Doubal, F., Armitage, P., Chappell, F., Carpenter, T., Muñoz Maniega, S., Farrall, A., Sudlow, C., Dennis, M., & Dhillon, B. (2009) · Annals of Neurology · doi:10.1002/ana.21549 · Cited by 364
“Several uncommon genetic mutations cause specific cerebral small-vessel disorders, such as cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy,(38) or the COL4A1 mutation that affects collagen synthesis resulting in friable arterioles and causing hemorrhage.(39) However, the smal…”
BackgroundThe glomerular basement membrane
Miner, J. H. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.02.031 · Cited by 337
“Heterozygous mutations in other regions of COL4A1 have been shown to cause stroke, porencephaly, and small vessel disease in both humans and mice [24], and kidney basement membrane defects have been observed in mutant mice [25,26].”
Self-citationThe pathology and pathophysiology of vascular dementia
Kalaria, R. N. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.030 · Cited by 339
Meuwissen, M. E. C., Halley, D. J. J., Smit, L. S., Lequin, M. H., Cobben, J. M., de Coo, R., van Harssel, J., Sallevelt, S., Woldringh, G., van der Knaap, M. S., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.210 · Cited by 329
Retinal Vascular Imaging: A New Tool in Microvascular Disease Research
Liew, G., Wang, J. J., Mitchell, P., & Wong, T. Y. (2008) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.108.784876 · Cited by 318
Kuo, D. S., Labelle-Dumais, C., & Gould, D. B. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds346 · Cited by 320
“Col4a1 mutant mice also have thinning and splitting of the glomerular basement membrane and functional renal pathology, including microalbuminurea and hematuria (80).”
BackgroundInfluentialSelf-citationA Sulfilimine Bond Identified in Collagen IV
Vanacore, R., Ham, A.-J. L., Voehler, M., Sanders, C. R., Conrads, T. P., Veenstra, T. D., Sharpless, K. B., Dawson, P. E., & Hudson, B. G. (2009) · Science · doi:10.1126/science.1176811 · Cited by 304
O'Donnell, C. J., Kavousi, M., Smith, A. V., Kardia, S. L. R., Feitosa, M. F., Hwang, S.-J., Sun, Y. V., Province, M. A., Aspelund, T., Dehghan, A., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.974899 · Cited by 304
Cuadrado-Godia, E., Dwivedi, P., Sharma, S., Ois Santiago, A., Roquer Gonzalez, J., Balcells, M., Laird, J., Turk, M., Suri, H. S., Nicolaides, A., et al. (2018) · Journal of Stroke · doi:10.5853/jos.2017.02922 · Cited by 286
Cerebral small vessel disease: Capillary pathways to stroke and cognitive decline
Østergaard, L., Engedal, T. S., Moreton, F., Hansen, M. B., Wardlaw, J. M., Dalkara, T., Markus, H. S., & Muir, K. W. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15606723 · Cited by 283
McCrea, H. J., & Ment, L. R. (2008) · Clinics in Perinatology · doi:10.1016/j.clp.2008.07.014 · Cited by 272
Migraine and stroke: a complex association with clinical implications
Kurth, T., Chabriat, H., & Bousser, M.-G. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70266-6 · Cited by 248
Self-citationCOL4A1 Mutations as a Monogenic Cause of Cerebral Small Vessel Disease: A Systematic Review
Lanfranconi, S., & Markus, H. S. (2010) · Stroke · doi:10.1161/strokeaha.110.581918 · Cited by 247
Fox, M. A., Sanes, J. R., Borza, D.-B., Eswarakumar, V. P., Fässler, R., Hudson, B. G., John, S. W. M., Ninomiya, Y., Pedchenko, V., Pfaff, S. L., et al. (2007) · Cell · doi:10.1016/j.cell.2007.02.035 · Cited by 239
“A naturally occurring COL4A1 mutant in which the fortieth exon is deleted was described previously (COL4A1Dex40; Gould et al., 2005, 2006).”
Self-citationFidler, A. L., Boudko, S. P., Rokas, A., & Hudson, B. G. (2018) · Journal of Cell Science · doi:10.1242/jcs.203950 · Cited by 224
“5, pre- to mid-gestation lethality (Smith et al., 2011) IV (α1α1α2) (G) Cerebral small vessel disease (Gould et al., 2006; Shah et al., 2012; Sibon et al., 2007) (G) Hereditary angiopathy with nephropathy aneurysms and muscle cramps (HANAC) (Plaisier et al., 2007, 2010) (G) Porencephaly 1…”
BackgroundDo in vivo Experimental Models Reflect Human Cerebral Small Vessel Disease? a Systematic Review
Hainsworth, A. H., & Markus, H. S. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.91 · Cited by 240
Imaging of intracranial haemorrhage
Kidwell, C. S., & Wintermark, M. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70041-3 · Cited by 240
Retinal Vascular Changes in Pre-Diabetes and Prehypertension
Nguyen, T. T., Wang, J. J., & Wong, T. Y. (2007) · Diabetes Care · doi:10.2337/dc07-0732 · Cited by 237
COL4A2 Mutations Impair COL4A1 and COL4A2 Secretion and Cause Hemorrhagic Stroke
Jeanne, M., Labelle-Dumais, C., Jorgensen, J., Kauffman, W. B., Mancini, G. M., Favor, J., Valant, V., Greenberg, S. M., Rosand, J., & Gould, D. B. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.11.022 · Cited by 219
Self-citationCerebral small vessel disease genomics and its implications across the lifespan
Sargurupremraj, M., Suzuki, H., Jian, X., Sarnowski, C., Evans, T. E., Bis, J. C., Eiriksdottir, G., Sakaue, S., Terzikhan, N., Habes, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19111-2 · Cited by 201
Retinal vascular tortuosity in persons with diabetes and diabetic retinopathy
Sasongko, M. B., Wong, T. Y., Nguyen, T. T., Cheung, C. Y., Shaw, J. E., & Wang, J. J. (2011) · Diabetologia · doi:10.1007/s00125-011-2200-y · Cited by 212
“More importantly, tortuous vessels signify the lack of support from cells of the vessel wall, which may reflect increased fragility and vulnerability to haemorrhage [30], which appear as retinopathy signs.”
BackgroundHeterozygous HTRA1 mutations are associated with autosomal dominant cerebral small vessel disease
Verdura, E., Hervé, D., Scharrer, E., Amador, M. D. M., Guyant-Maréchal, L., Philippi, A., Corlobé, A., Bergametti, F., Gazal, S., Prieto-Morin, C., et al. (2015) · Brain · doi:10.1093/brain/awv155 · Cited by 200
Self-citationMancuso, M., Arnold, M., Bersano, A., Burlina, A., Chabriat, H., Debette, S., Enzinger, C., Federico, A., Filla, A., Finsterer, J., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14183 · Cited by 193
“Missense or null variants in COL4A1 and COL4A2 cause an autosomal dominant cSVD of the haemorrhagic type that can be associated with extracerebral clinical manifestations [20].”
BackgroundSelf-citationExtracellular matrix scaffolding in angiogenesis and capillary homeostasis
Marchand, M., Monnot, C., Muller, L., & Germain, S. (2019) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2018.08.007 · Cited by 205
Greenberg, S. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068043 · Cited by 172
A unique covalent bond in basement membrane is a primordial innovation for tissue evolution
Fidler, A. L., Vanacore, R. M., Chetyrkin, S. V., Pedchenko, V. K., Bhave, G., Yin, V. P., Stothers, C. L., Rose, K. L., McDonald, W. H., Clark, T. A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318499111 · Cited by 171
Genetics of anterior segment dysgenesis disorders
Reis, L. M., & Semina, E. V. (2011) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e328349412b · Cited by 159
Reed, M. J., Damodarasamy, M., & Banks, W. A. (2019) · Tissue Barriers · doi:10.1080/21688370.2019.1651157 · Cited by 157
“Modest mutations in the Col4α1 gene are associated with fragile vessels that predispose to stress-induced hemorrhage and adult-onset stroke in humans.(103,104) Null mutations of Col IV in mice are embryonic lethal due, in part, to impaired BM stability.”
BackgroundHennet, T. (2019) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2019.01.015 · Cited by 159
Genome wide analysis reveals association of a FTO gene variant with epigenetic changes
Almén, M. S., Jacobsson, J. A., Moschonis, G., Benedict, C., Chrousos, G. P., Fredriksson, R., & Schiöth, H. B. (2012) · Genomics · doi:10.1016/j.ygeno.2011.12.007 · Cited by 157
Glomerular basement membrane composition and the filtration barrier
Miner, J. H. (2011) · Pediatric Nephrology · doi:10.1007/s00467-011-1785-1 · Cited by 172
“It is worth mentioning here that dominant mutations in human COL4A1 also cause several forms of kidney disease with diverse extrarenal manifestations [30, 31].”
BackgroundSelf-citationA Vessel for Change: Endothelial Dysfunction in Cerebral Small Vessel Disease
Quick, S., Moss, J., Rajani, R. M., & Williams, A. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.11.003 · Cited by 166
Jeanne, M., Jorgensen, J., & Gould, D. B. (2015) · Circulation · doi:10.1161/circulationaha.114.013395 · Cited by 146
“Modeling patients with COL4A1 mutations, surviving Col4a1+/Δex41 mice have multisystem disorders, including fully penetrant cerebrovascular disease presenting as porencephaly and prenatal, perinatal, and recurrent multifocal ICHs.(17,27) At embryonic day (E) 10.”
InfluentialSelf-citationMutation of FOXC1 and PITX2 induces cerebral small-vessel disease
French, C. R., Seshadri, S. S., DeStefano, A. L., Fornage, M., Arnold, C. R., Gage, P. J., Skarie, J. M., Dobyns, W. B., Millen, K. J., Liu, T., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75109 · Cited by 156
“In the same way, the vascular basement membrane’s contribution (COL4A1 and COL4A2) (3, 4) to juvenile stroke phenotypes further stimulated investigation of the cellular components (endothelial and mural cells) upon which brain vascular integrity depends.”
BackgroundCOL4A1 mutation in Axenfeld–Rieger anomaly with leukoencephalopathy and stroke
Sibon, I., Coupry, I., Menegon, P., Bouchet, J., Gorry, P., Burgelin, I., Calvas, P., Orignac, I., Dousset, V., Lacombe, D., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21191 · Cited by 147
“1) is in accordance with the increased risk, described in humans and mouse models, of cerebrovascular complications related to the stress of delivery.(6,7) In contrast, a relatively low MMSE score was noted among all adult subjects affected by the disease (Cases III.”
BackgroundResultClinical spectrum of type IV collagen (COL4A1) mutations: a novel genetic multisystem disease
Vahedi, K., & Alamowitch, S. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32834232c6 · Cited by 142
Self-citationNeurologic phenotypes associated with COL4A1 / 2 mutations: Expanding the spectrum of disease
Zagaglia, S., Selch, C., Nišević, J. R., Mei, D., Michalak, Z., Hernández-Hernández, L., Krithika, S., Vezyroglou, A., Varadkar, S., Pepler, A., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000006567 · Cited by 155
“The most typical is through predisposition to hemorrhagic and ischemic insults, as demonstrated by mouse models.(3,4) MCD were also associated with Col4a1 mutations, as a result of defects of cortical lamination.”
BackgroundLabelle‐Dumais, C., Dilworth, D. J., Harrington, E. P., de Leau, M., Lyons, D., Kabaeva, Z. T., Manzini, M. C., Dobyns, W. B., Walsh, C. A., Michele, D. E., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002062 · Cited by 153
“The mutation we identified in mice (referred to as Col4a1Dex40) disrupts a splice acceptor site, causing exon 40 to be skipped and concomitant deletion of 17 amino acids from the collagen triple helical domain which interferes with proper folding, assembly and secretion of heterotrimeric COL4A1 and COL4A2 [21,22].”
BackgroundInfluentialSelf-citationCerebrovascular disease related to COL4A1 mutations in HANAC syndrome
Alamowitch, S., Plaisier, E., Favrole, P., Prost, C., Chen, Z., Van Agtmael, T., Marro, B., & Ronco, P. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c3fd12 · Cited by 144
Basement membranes and human disease
Agtmael, T. V., & Bruckner‐Tuderman, L. (2009) · Cell and Tissue Research · doi:10.1007/s00441-009-0866-y · Cited by 156
“2005), its location within the gene and genetic and environmental modifiers(Gould et al. 2007; Gould et al. 2006).”
BackgroundInfluentialMicrovascular Structure and Network in the Retina of Patients With Ischemic Stroke
Ong, Y., Silva, D. A. D., Cheung, C. Y.-L., Chang, H., Chen, C., Wong, M. C., Wong, T. Y., & Ikram, M. K. (2013) · Stroke · doi:10.1161/strokeaha.113.001741 · Cited by 157
“In the retina, vessel rarefaction and collapse, leading to reduction in vascular fractal dimension, is associated with hypoxia(23); whereas increased vessel tortuosity is indicative of vessel wall dysfunction and blood–retina barrier damage.(24,25) Our findings suggest that similar pathological changes in the small ve…”
BackgroundGutiérrez, J., Escalante, T., Rucavado, A., Herrera, C., & Fox, J. (2016) · Toxins · doi:10.3390/toxins8100304 · Cited by 131
Genotype-phenotype correlations in pathology caused by collagen type IV alpha 1 and 2 mutations
Jeanne, M., & Gould, D. B. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.10.003 · Cited by 152
Self-citationHypomorphic Notch 3 alleles link Notch signaling to ischemic cerebral small-vessel disease
Arboleda-Velasquez, J. F., Manent, J., Lee, J. H., Tikka, S., Ospina, C., Vanderburg, C. R., Frosch, M. P., Rodríguez-Falcón, M., Villen, J., Gygi, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101964108 · Cited by 138
The pathogenesis of cerebral small vessel disease and vascular cognitive impairment
Markus, H. S., & Joutel, A. (2025) · Physiological Reviews · doi:10.1152/physrev.00028.2024 · Cited by 163
COL4A1 mutations in patients with sporadic late‐onset intracerebral hemorrhage
Weng, Y., Sonni, A., Labelle‐Dumais, C., de Leau, M., Kauffman, W. B., Jeanne, M., Biffi, A., Greenberg, S. M., Rosand, J., & Gould, D. B. (2012) · Annals of Neurology · doi:10.1002/ana.22682 · Cited by 134
“We identified a COL4A1 mutation in a French family diagnosed with a multisystem small-vessel disease that not only affected the cerebrovascular system but also the renal and retinal vasculature, demonstrating that COL4A1 mutations affect multiple organ systems in human patients.(5) More recently, mutations were identi…”
BackgroundSelf-citationCol4a1 mutation causes endoplasmic reticulum stress and genetically modifiable ocular dysgenesis
Gould, D. B., Marchant, J. K., Savinova, O. V., Smith, R. S., & John, S. W. M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm024 · Cited by 132
“To date, six different COL4A1 mutant alleles have been reported in human patients (6,7,45).”
InfluentialSelf-citationAssembly, heterogeneity, and breaching of the basement membranes
Glentis, A., Gurchenkov, V., & Vignjevic, D. M. (2014) · Cell Adhesion & Migration · doi:10.4161/cam.28733 · Cited by 131
Tan, A. P., Svrckova, P., Cowan, F. M., Chong, W. K., & Mankad, K. (2018) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2018.04.008 · Cited by 138
Joutel, A., Haddad, I., Ratelade, J., & Nelson, M. T. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.62 · Cited by 128
“Similar defects have been described in the BM of cerebral blood vessels from Col4a1þ/ ex41 mice, a well-characterized mouse model that expresses a mutant collagen alpha-1(IV) chain with a 17-aminoacid in-frame deletion.(42,43) A large proportion of COL4A1 and COL4A2 mutations are missense mutations resulting in the su…”
BackgroundCollagens in the developing and diseased nervous system
Hübert, T., Grimal, S., Carroll, P., & Fichard, A. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8561-9 · Cited by 144
Khan, A., Kalaria, R. N., Corbett, A., & Ballard, C. (2016) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988716654987 · Cited by 125
Pathophysiology of cerebral small vessel disease: a journey through recent discoveries
Dupré, N., Drieu, A., & Joutel, A. (2024) · Journal of Clinical Investigation · doi:10.1172/jci172841 · Cited by 137
Review: Molecular genetics and pathology of hereditary small vessel diseases of the brain
Yamamoto, Y., Craggs, L., Baumann, M., Kalimo, H., & Kalaria, R. N. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01147.x · Cited by 125
Transcriptomics of Post-Stroke Angiogenesis in the Aged Brain
Bugă, A. M., Mărgăritescu, C., Scholz, C. J., Radu, E., Zelenak, C., & Popa‐Wagner, A. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00044 · Cited by 131
“Collagen, type IV, alpha 2 (COL4A2) is an abundant component of BL of the cerebral vasculature and Col4a2 mutations cause small-vessel disease and hemorrhagic stroke (Gould et al., 2006; Jeanne et al., 2012).”
BackgroundCOL4A2 mutation associated with familial porencephaly and small-vessel disease
Verbeek, E., Meuwissen, M. E. C., Verheijen, F. W., Govaert, P. P., Licht, D. J., Kuo, D. S., Poulton, C. J., Schot, R., Lequin, M. H., Dudink, J., et al. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.20 · Cited by 132
Self-citationHerrera, C., Escalante, T., Voisin, M.-B., Rucavado, A., Morazán, D., Macêdo, J. K. A., Calvete, J. J., Sanz, L., Nourshargh, S., Gutiérrez, J. M., et al. (2015) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0003731 · Cited by 116
“Moreover, a genetic disease associated with mutations in the COL4A1 gene and reduction in the expression of α1 subunit are associated with pathological alterations in microvessels and hemorrhage in mice, and have been linked to hemorrhagic stroke in humans [39].”
BackgroundCOL4A1 mutation in two preterm siblings with antenatal onset of parenchymal hemorrhage
de Vries, L. S., Koopman, C., Groenendaal, F., Van Schooneveld, M., Verheijen, F. W., Verbeek, E., Witkamp, T. D., van der Worp, H. B., & Mancini, G. (2009) · Annals of Neurology · doi:10.1002/ana.21525 · Cited by 121
“Still, surgically delivered pups did occasionally have small hemorrhages visible through the skin, suggesting that even the pressure in utero was sufficient to cause these smaller lesions.(17) Based on these findings, it Fig 2.”
BackgroundInfluentialJoutel, A., & Faraci, F. M. (2014) · Stroke · doi:10.1161/strokeaha.113.002878 · Cited by 112
“For example, retinal arteriolar tortuosity and ocular anterior segment dysgenesis were highly penetrant in mice with the C57BL/6J background and almost absent in mice with the mixed CAST-BL/6 background.(30)”
BackgroundInfluentialChen, Z.-L., Yao, Y., Norris, E. H., Kruyer, A., Jno-Charles, O., Akhmerov, A., & Strickland, S. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201212032 · Cited by 115
Blood Pressure Lowering for Primary and Secondary Prevention of Stroke
Zhang, H., Thijs, L., & Staessen, J. A. (2006) · Hypertension · doi:10.1161/01.hyp.0000231939.40959.60 · Cited by 117
COL4A1 Mutation in a Patient With Sporadic, Recurrent Intracerebral Hemorrhage
Vahedi, K., Kubis, N., Boukobza, M., Arnoult, M., Massin, P., Tournier-Lasserve, E., & Bousser, M.-G. (2007) · Stroke · doi:10.1161/strokeaha.106.475194 · Cited by 113
Self-citationGenome-wide association study of cerebral small vessel disease reveals established and novel loci
Chung, J., Marini, S., Pera, J., Norrving, B., Jiménez-Conde, J., Roquer, J., Fernández‐Cadenas, I., Tirschwell, D., Selim, M. H., Brown, D. L., et al. (2019) · Brain · doi:10.1093/brain/awz233 · Cited by 126
Mochida, G. H., Ganesh, V. S., Felie, J. M., Gleason, D., Hill, R. S., Clapham, K. R., Rakiec, D. P., Tan, W., Akawi, N. A., Al‐Saffar, M., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.10.026 · Cited by 116
Critical role of microvasculature basal lamina in ischemic brain injury
Wang, C. X., & Shuaib, A. M. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.07.006 · Cited by 114
Role of the Podocyte (and Glomerular Endothelium) in Building the GBM
Abrahamson, D. R. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.06.005 · Cited by 112
Cathepsin A–related arteriopathy with strokes and leukoencephalopathy (CARASAL)
Bugiani, M., Kevelam, S. H., Bakels, H. S., Waisfisz, Q., Ceuterick-de Groote, C., Niessen, H. W. M., Abbink, T. E. M., Lesnik Oberstein, S. A. M. J., & van der Knaap, M. S. (2016) · Neurology · doi:10.1212/wnl.0000000000003251 · Cited by 111
Verdura, E., Hervé, D., Bergametti, F., Jacquet, C., Morvan, T., Prieto-Morin, C., Mackowiak, A., Manchon, É., Hosseini, H., Cordonnier, C., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24782 · Cited by 114
Self-citationMutations in a P-Type ATPase Gene Cause Axonal Degeneration
Zhu, X., Libby, R. T., de Vries, W. N., Smith, R. S., Wright, D. L., Bronson, R. T., Seburn, K. L., & John, S. W. M. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002853 · Cited by 105
Self-citationGenetic factors in cerebral small vessel disease and their impact on stroke and dementia
Haffner, C., Malik, R., & Dichgans, M. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.71 · Cited by 109
“Triggered by observations in Col4a1 mutant mice Gould et al.(37,38) found that heterozygous COL4A1 mutations in humans are associated with familial SVD and a wide clinical spectrum including lacunar stroke, ICH, WMH, and cerebral microbleeds.”
BackgroundThe blood–brain barrier: a help and a hindrance
Rust, R., Yin, H. R., Buil, B. A., Sagare, A. P., & Kisler, K. (2025) · Brain · doi:10.1093/brain/awaf068 · Cited by 119
“154,155 Furthermore, rare human mutations in genes encoding endothelial junctional proteins OCL, 156 JAM3 157 and basement membrane components COL4A1 158 and COL4A2, 159 resulted in impairments of the BBB.”
Novel COL4A1 mutations associated with HANAC syndrome: A role for the triple helical CB3[IV] domain
Plaisier, E., Chen, Z., Gekeler, F., Benhassine, S., Dahan, K., Marro, B., Alamowitch, S., Paques, M., & Ronco, P. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33659 · Cited by 105
“…associatedwith inherited cerebral small vessel disease (CSVD), characterized by overlapping clinical and brain imaging features with porencephaly, that included stroke, leukoencephalopathy, infarct and cerebral hemorrhages (OMIM 607595) [Gould et al., 2006; Vahedi et al., 2007; Shah et al., 2010].”
BackgroundGenetics of Cerebral Small Vessel Disease
Choi, J. C. (2015) · Journal of Stroke · doi:10.5853/jos.2015.17.1.7 · Cited by 104
“COL4A1-related cerebral SVD Mutations in a gene encoding type IV collagen α1 (COL4A1) were initially associated with porencephaly and infantile hemiparesis,(67) however, these mutations have been later found to cause cerebral SVD even in adulthood.(68,69) In a systemic review of 52 carriers of the COL4A1 mutation, str…”
BackgroundDe Novo and Inherited Mutations in COL4A2, Encoding the Type IV Collagen α2 Chain Cause Porencephaly
Yoneda, Y., Haginoya, K., Arai, H., Yamaoka, S., Tsurusaki, Y., Doi, H., Miyake, N., Yokochi, K., Osaka, H., Kato, M., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.11.016 · Cited by 116
Vitali, P., Migliaccio, R., Agosta, F., Rosen, H., & Geschwind, M. (2008) · Seminars in Neurology · doi:10.1055/s-0028-1083695 · Cited by 98
Cell–matrix interactions in muscle disease
Carmignac, V., & Durbeej, M. (2011) · The Journal of Pathology · doi:10.1002/path.3020 · Cited by 113
Basement Membrane Defects in Genetic Kidney Diseases
Chew, C., & Lennon, R. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00011 · Cited by 105
“Smallvessel disease affecting the brain and eye has also been described in a single family with COL4A1 mutation (78).”
BackgroundGenome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke
Traylor, M., Zhang, C. R., Adib‐Samii, P., Devan, W. J., Parsons, O., Lanfranconi, S., Gregory, S., Cloonan, L. K., Falcone, G. J., Radmanesh, F., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000002263 · Cited by 112
Current concepts and clinical applications of stroke genetics
Falcone, G. J., Malik, R., Dichgans, M., & Rosand, J. M. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70029-8 · Cited by 107
Craggs, L., Yamamoto, Y., Deramecourt, V., & Kalaria, R. N. (2014) · Brain Pathology · doi:10.1111/bpa.12177 · Cited by 102
“Thus, COL4A1-related disorders show a range of phenotypes with overlapping features, including autosomal dominant type 1 porencephaly (40), brain small vessel disease with hemorrhage (41), brain small vessel disease with Axenfeld-Rieger anomaly (99), and hereditary angiopathy with nephropathy, aneurysms and muscle cra…”
BackgroundCrucial role for the VWF A1 domain in binding to type IV collagen
Flood, V. H., Schlauderaff, A. C., Haberichter, S. L., Slobodianuk, T. L., Jacobi, P. M., Bellissimo, D. B., Christopherson, P. A., Friedman, K. D., Gill, J. C., Hoffmann, R. G., et al. (2015) · Blood · doi:10.1182/blood-2014-11-610824 · Cited by 94
The Genetic Architecture of Intracerebral Hemorrhage
Rost, N. S., Greenberg, S. M., & Rosand, J. M. (2008) · Stroke · doi:10.1161/strokeaha.107.501650 · Cited by 100
Metadata
- Authors
- Gould, D. B., Phalan, F. C., van Mil, S. E., Sundberg, J. P., Vahedi, K., Massin, P., Bousser, M. G., Heutink, P., Miner, J. H., Tournier-Lasserve, E., & John, S. W. M.
- Affiliations
- Howard Hughes Medical Institute (US)
- Jackson Laboratory (US)
- Assistance Publique – Hôpitaux de Paris (FR)
- Inserm (FR)
- Hôpital Lariboisière (FR)
- Washington University in St. Louis (US)
- Tufts University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-04-06
- Volume
- 354
- Issue
- 14
- Pages
- 1489-1496
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2082432121
- Cited by
- 581
- References
- 18
- Citations by year
- 2026: 24 · 2025: 29 · 2024: 38 · 2023: 21 · 2022: 18 · 2021: 33 · 2020: 24 · 2019: 30 · 2018: 38 · 2017: 28 · 2016: 24 · 2015: 34 · 2014: 39 · 2013: 32 · 2012: 33
- FWCI
- 17.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
- Funders
- National Eye Institute (EY117211)
- National Cancer Institute (#CA34196, P30CA034196)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK064687, DK064687)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- COL4A1, cerebral small vessel disease, intracerebral hemorrhage, hemorrhagic stroke, ischemic stroke, COL4A1 mutation, mouse model, birth trauma, cerebrovascular disease, genetic susceptibility, environmental stress
- MeSH terms
- Animals, Brain, Cerebral Hemorrhage, Female, Humans, Male, Mice, Inbred C57BL, Mice, Mutant Strains, Microcirculation, Mutation, Pedigree, Renal Artery, Retinal Artery, Risk Factors, Stress, Physiological, Genetic Predisposition to Disease, Stroke, Collagen Type IV, Glomerular Basement Membrane, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.